Skip to main content

Ernexa Therapeutics Inc.

ERNA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000748592

No open-market purchases or sales by Ernexa Therapeutics Inc. insiders were filed in the last 90 days; 10 institutions reported holding it in 13F filings for Q2 2026, worth $236.2K in total; no superinvestor holds it.

Other share classesERNAW

Superinvestors holding ERNA, Q2 2026

See all superinvestors

No superinvestor reported holding ERNA in Q2 2026.